On the recordMay 22, 2013
Where do we draw the line? Because I think as legislation is developed, and your testimony is that you do not want and it is not appropriate to capture the community pharmacists who are compounding.
Source
congress.govEditor's note · Context
Castor seeks clarity on legislation regarding community pharmacists and large-scale manufacturers.
Share & report
More from Kathy Castor
Apr 17, 2023
Decades of HHS OIG enforcement and oversight proved the adage that fraudsters follow the money.
Mar 22, 2023
TikTok could be designed to minimize the harm to kids, but a decision was made to aggressively addict kids in the name of profits.
Apr 17, 2023
Our work has also raised concerns regarding improper denials of Medicare covered services.
Mar 28, 2023
I want to start by expressing my appreciation for the inspectors general, the GAO, all that you do to ensure that our agencies are implementing Federal laws effectively and that they are allocating Federal funds responsibly.
Other voices in this conversation
